Cargando…
Triple Antithrombotic Therapy vs. Double Antithrombotic Therapy: One Scenario, 8 Questions, Many Conclusions
In patients with atrial fibrillation undergoing percutaneous coronary intervention with the placement of stents, a triple antithrombotic therapy is empirically established, which consists of a combination of dual antithrombotic therapy (aspirin plus a P2Y12 inhibitor) and an oral anticoagulant agent...
Autores principales: | Aloia, Elio, Orselli, Paolo, Sciaccaluga, Carlotta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719388/ https://www.ncbi.nlm.nih.gov/pubmed/30636613 http://dx.doi.org/10.2174/1573403X15666190111095438 |
Ejemplares similares
-
The sunset of triple antithrombotic therapy for atrial fibrillation patients
por: Capranzano, Piera
Publicado: (2019) -
Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018) -
Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020) -
Randomised trials and meta-analyses of double vs triple antithrombotic therapy for atrial fibrillation-ACS/PCI: A critical appraisal
por: Galli, Mattia, et al.
Publicado: (2020) -
Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)